NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Medical Letter on the CDC & FDA

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Acute Coronary Syndrome



Antiplatelet therapy has an essential role in treating acute coronary syndromes



February 20th, 2005

A recent report on the role of antiplatelet therapy in cardiovascular disease focused on acute coronary syndromes.

According to the report from the United States, "The acute coronary syndromes (ACS), consisting of ST-segment elevation myocardial infarction (STEMI), non-STEMI (NSTEMI), and unstable angina, remain a leading cause of death in the United States. Through the process of atherothrombosis, underlying atherosclerosis can progress to an acute ischemic coronary event. This disease mechanism is also common to ischemic stroke and peripheral arterial disease."

J.J. Cavendish and colleagues of the U.S. Navy continued, "As ACS is a heterogeneous...


Source: Medical Letter on the CDC & FDA (2005-02-20)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login